2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic

2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic

Item
http://www.wikidata.org/entity/Q33227259
SSR504734 enhances basal expression of prepulse inhibition but exacerbates the disruption of prepulse inhibition by apomorphine.Glycine transport inhibitors for the treatment of schizophreniaGlycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.Dopaminergic regulation of limbic-striatal interplay.Effects of adolescent exposure to cocaine on locomotor activity and extracellular dopamine and glutamate levels in nucleus accumbens of DBA/2J miceAltered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1Deletion of glycine transporter 1 (GlyT1) in forebrain neurons facilitates reversal learning: enhanced cognitive adaptability?Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder.Glycine Transporters and Its Coupling with NMDA Receptors.
P2860

2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic

Item
http://www.wikidata.org/entity/Q33227259
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
2-Chloro-N-[(S)-phenyl [(2S)-p ...... via an enhanced glutamatergic
@ast
2-Chloro-N-[(S)-phenyl [(2S)-p ...... via an enhanced glutamatergic
@en
type
label
2-Chloro-N-[(S)-phenyl [(2S)-p ...... via an enhanced glutamatergic
@ast
2-Chloro-N-[(S)-phenyl [(2S)-p ...... via an enhanced glutamatergic
@en
prefLabel
2-Chloro-N-[(S)-phenyl [(2S)-p ...... via an enhanced glutamatergic
@ast
2-Chloro-N-[(S)-phenyl [(2S)-p ...... via an enhanced glutamatergic
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
2-Chloro-N-[(S)-phenyl [(2S)-p ...... via an enhanced glutamatergic
@en
P2093
P304
P31
P356
10.1016/J.NEUROSCIENCE.2005.09.003
P407
P433
P478
P577
P698
P921